IDEXX Laboratories (NASDAQ:IDXX) dropped slightly amid mild profit booking and the last known price was $89.04 per share. The price decreased by -0.09 points or -0.1% which made the investors to buy on weakness. For the latest trading session, the net money flow was recorded at $8.69 million. The total upticks were valued at $12.27 million and the total downticks aggregated to $3.58 million, thereby putting the up/down ratio at 3.43,. The shares have seen a change in the share price of 1.57% on a weekly basis.In a big block trade which occurred today, the total uptick value was $9.06 million and the total downtick value was $0, resulting in an up/down ratio of 0. The net money flow for the block trade was calculated to be $9.06 million.
The stock has recorded a 20-day Moving Average of 0.79% and the 50-Day Moving Average is 4.3%. The company shares have rallied 35.52% in the past 52 Weeks. On May 26, 2016 The shares registered one year high of $91.94 and one year low was seen on July 7, 2015 at $61.58. The 50-day moving average is $88.13 and the 200 day moving average is recorded at $77.34. S&P 500 has rallied 1.93% during the last 52-weeks.
IDEXX Laboratories (NASDAQ:IDXX): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $89.13 and $88.83 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $89.82. The buying momentum continued till the end and the stock did not give up its gains. It closed at $89.66, notching a gain of 0.59% for the day. The total traded volume was 584,387 . The stock had closed at $89.13 on the previous day.
Currently the company Insiders own 2.79% of IDEXX Laboratories shares according to the proxy statements. Institutional Investors own 96.3% of IDEXX Laboratories shares. During last six month period, the net percent change held by insiders has seen a change of -4.76%. On the companys insider trading activities, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director of Idexx Laboratories Inc /De, End William T had sold 4,924 shares worth of $422,824 in a transaction dated May 5, 2016. In this transaction, 4,924 shares were sold at $85.87 per share.
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include Companion Animal Group (CAG), Water, Livestock, Poultry and Dairy, and Other. Its Products and services include point-of-care veterinary diagnostic products; veterinary reference laboratory diagnostic and consulting services; practice management systems and services, and digital imaging systems; biological materials testing, laboratory animal diagnostic instruments and services; diagnostic, health-monitoring and food safety testing products for livestock, poultry and dairy; products that test water for microbiological contaminants, and point-of-care electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.